[{"Assets_0_Q3_USD":66164000000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":10035000000.0,"NetIncomeLoss_1_Q3_USD":2747000000.0,"NetIncomeLoss_3_Q3_USD":7513000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":1515000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":1561000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":1511000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":1556000000.0,"StockholdersEquity_0_Q3_USD":-2921000000.0,"EarningsPerShareBasic_1_Q3_USD":1.81,"EarningsPerShareBasic_3_Q3_USD":4.81,"EarningsPerShareDiluted_1_Q3_USD":1.81,"EarningsPerShareDiluted_3_Q3_USD":4.79,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":8236000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":24448000000.0,"Ticker":"ABBV","CIK":"1551152","name":"ABBVIE INC.","OfficialName":"AbbVie Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"276158647867.0","Country":"United States","Sector":"Health Care","Industry":"Other Pharmaceuticals","Market":"NYSE","SP500":"SP500","filed":"20181107"}]